Journal of Clinical Medicine (May 2023)

The Gastropack Access System as a Model to Access Gastroenterology Services for Gastroscopy Appropriateness in Patients with Upper Gastrointestinal Symptoms: A Comparison with the Open Access System

  • Liza Ceroni,
  • Francesca Lodato,
  • Paolo Tubertini,
  • Giovanni Marasco,
  • Alessia Gazzola,
  • Maurizio Biselli,
  • Cristiano Fabbri,
  • Federica Buonfiglioli,
  • Francesco Ferrara,
  • Ramona Schiumerini,
  • Andrea Fabbri,
  • Alessandra Tassoni,
  • Carlo Descovich,
  • Sandra Mondini,
  • Cesare Tosetti,
  • Valerio Veduti,
  • Mario De Negri,
  • Alessandro Fini,
  • Stefano Guicciardi,
  • Massimo Romanelli,
  • Giuseppe Giovanni Navarra,
  • Giovanni Barbara,
  • Vincenzo Cennamo,
  • on behalf of Gastropack System Study Group

DOI
https://doi.org/10.3390/jcm12093343
Journal volume & issue
Vol. 12, no. 9
p. 3343

Abstract

Read online

Esophagogastroduodenoscopy (EGD) appropriateness in Open-Access System (OAS) is a relevant issue. The Gastropack Access System (GAS) is a new system to access gastroenterological services, based on the partnership between Gastroenterologists and GPs. This study aims to evaluate if GAS is superior to OAS in terms of EGDS appropriateness. Secondarily, we evaluated the diagnostic yield of EGDS according to ASGE guidelines. The GAS was developed in an area of Bologna where General Practitioners (GPs) could decide to directly prescribe EGDS through OAS or referring to GAS, where EGDS can be scheduled after contact between GPs and specialists sharing a patient’s clinical information. Between 2016 and 2019, 2179 cases (M:F = 861:1318, median age 61, IQR 47.72) were referred to GAS and 1467 patients (65%) had a prescription for EGDS; conversely, 874 EGDS were prescribed through OAS (M:F = 383:491; median age 58 yrs, IQR 45.68). Indication was appropriate in 92% in GAS (1312/1424) versus 71% in OAS (618/874), p p < 0.001). Adherence to ASGE guidelines was not related to CSEF; however, surveillance for pre-malignant conditions was independently related to CSEF. All neoplasm were observed in appropriate EGD. GAS is an innovative method showing extremely high rates of appropriateness. ASGE guidelines confirmed their validity for cancer detection, but their performance for the detection of other conditions needs to be refined.

Keywords